Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 10.8B | 9.8B | 10.2B | 9.6B |
Cost of revenue | 6.5B | 5.9B | 6.2B | 5.8B |
Gross profit | 4.3B | 3.9B | 4.0B | 3.8B |
Operating expense | ||||
Research & development | 717.2M | 695.8M | 670.2M | 660.8M |
Selling general and admin | 1.6B | 1.5B | 2.0B | 1.5B |
Other operating expenses | 594.2M | 570.3M | 578.9M | 586.6M |
Operating income | 1.2B | 1.0B | 657.4M | 905.9M |
Non operating interest income | ||||
Income | 154.5M | 144.3M | 163.1M | 166.5M |
Expense | 92.2M | 89.6M | 99.9M | 122.1M |
Other income expense | -16.2M | 79.4M | 55.5M | 1.4B |
Pretax income | 1.3B | 1.2B | 776.1M | 2.4B |
Tax provision | 121.2M | -343.2M | -5.1B | 134.9M |
Net income | 1.2B | 1.5B | 5.9B | 2.2B |
Basic EPS | 0.7 | 0.9 | 3.3 | 1.2 |
Diluted EPS | 0.6 | 0.8 | 3.2 | 1.2 |
Basic average shares | 1.8B | 1.8B | 1.8B | 1.8B |
Diluted average shares | 1.8B | 1.8B | 1.8B | 1.8B |
EBITDA | 1.5B | 1.3B | 897.3M | 1.2B |
Net income from continuing op. | 1.2B | 1.5B | 5.9B | 2.2B |
Minority interests | 4.3M | 1.7M | -15.4M | 11.1M |
Preferred stock dividends | — | — | — | — |